InvestorsHub Logo
Followers 6
Posts 1400
Boards Moderated 0
Alias Born 08/24/2014

Re: trading.jeff post# 35676

Thursday, 08/18/2016 1:03:27 PM

Thursday, August 18, 2016 1:03:27 PM

Post# of 48316
What investors should understand about Merck is that they have become a more cautious company since their troubles with Vioxx. Ken Frazier was instrumental in steering them back from the dead and he is more focused on diversification and long term shareholder value. Immunotherapy is on the radar of all Big Pharma and Oncosec having an extremely safe platform will spark alot of interest when combo trial results are released.....as long as those results are good.....I think they will be great actually.